Drug Profile
Research programme: GPR119 agonists - GlaxoSmithKline
Alternative Names: GSK 047B; GSK 263ALatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Small molecules; Sulfones; Sulfoxides
- Mechanism of Action GPR119 protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA (PO, Suspension)